• Dosimetry Characterization of a Multibeam Radiotherapy Treatment for Age-Related Macular Degeneration
• Kilovoltage Stereotactic Radiosurgery for Age-related Macular Degeneration: Assessment of Optic Nerve Dose and Patient Effective Dose

• 1/5/2010 - Oraya Therapeutics Initiates First Ever Sham-Controlled Study of Radiation Therapy for Wet AMD
• 10/20/2009 - Oraya Therapeutics to present at Ophthalmology Innovations Summit

For inquiries regarding Oraya Therapeutics or the IRay™ stereotactic radiosurgical device, please send an email to info@orayainc.com.

For inquiries regarding employment at Oraya Therapeutics, please send an email to HR@orayainc.com.

To reach the Oraya Therapeutics file exchange website, please click here.
To reach the Oraya Therapeutics web mail site, authorized users please click here.
To reach the Oraya Therapeutics VPN site, authorized users please click here.

Oraya Therapeutics, Inc.

8000 Jarvis Ave.
Newark, CA 94560
(510) 456-3700